OS Therapies (NYSE:OSTX) Stock Price Down 0.9% – Time to Sell?

Shares of OS Therapies Inc (NYSE:OSTX) fell 0.9% on Monday . The stock traded as low as $2.99 and last traded at $2.99. 23,802 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 180,573 shares. The stock had previously closed at $3.02.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Brookline Capital Management raised OS Therapies to a “strong-buy” rating in a research note on Thursday, August 22nd. EF Hutton Acquisition Co. I upgraded OS Therapies to a “strong-buy” rating in a research report on Tuesday, September 3rd.

OS Therapies Stock Performance

The company’s fifty day simple moving average is $3.48.

OS Therapies (NYSE:OSTX) last posted its earnings results on Wednesday, August 14th. The company reported ($0.26) earnings per share (EPS) for the quarter. On average, equities research analysts anticipate that OS Therapies Inc will post -0.47 earnings per share for the current year.

About OS Therapies

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.